Diabetic Retinal Disease Rates Narrow by Diabetes Type

• by Andrea Surnit

• April 15, 2026

FDA Expands Afrezza to Pediatric Diabetes

The decision was supported by the phase 3 INHALE-1 trial and additional long-term safety, efficacy, and exposure data.

• by Kathryn Wighton

• May 29, 2026

• 3 min

Association between the composite CRP–TyG index and incident malignancy risk in hospitalized patients with diabetes: a retrospective cohort study with nonlinear effect analysis

• by Xinyuan Cui, Mengru Yuan, Yanting Mao, Bojin Xu, Haiping Zhou, Shan Huang, Wenfang Peng

• May 18, 2026

Metabolic and bariatric surgery in mild obesity: mid-term outcomes and safety in an Asian population

• by Wanying Zhong, Lijun Chen, Yuanhao Huang, Dalong Zhu, Wenjuan Tang, Yuqin Ouyang, Xuehui Chu, Wenhuan Feng

• May 20, 2026